top of page
![Pattern 5 [Converted]-01.png](https://static.wixstatic.com/media/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png/v1/fill/w_980,h_718,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png)
Knowledge Center
Search


Part 13 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Interstitial Lung Disease
Dr. Maria Padilla, MD, stresses early ILD diagnosis, highlighting low-dose CT scans for better outcomes and new therapeutic interventions.


Part 12 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Emphysema and COPD
Dr. Rizzo stresses the need for early COPD detection, clear guidelines, and the role of pulmonologists and new drugs in improving outcomes.


Part 11 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Introduction
Dr. Mulshine highlights early detection's role in preventing thoracic disease deaths, advocating for screening effectiveness over quantity.


Part 10 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 1: Panel Discussions
Experts discuss integrating lung cancer screening with cardiovascular prevention using AI and low-dose CT scans to enhance early detection.


Part 9 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 1: Valvular Disease
Dr. Sharma stresses the need for early detection and transcatheter procedures for valvular heart disease, noting higher prevalence in women.


Part 8 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 1: Atrial Fibrillation
Dr. Reddy highlights AF's rising prevalence and risks, stressing early detection and anticoagulation to reduce stroke in high-risk patients.


Part 7 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 1: Heart Failure
Dr. Sean Pinney stresses the importance of early detection of heart failure, noting disparities and the role of AI-enhanced screening tools.


Part 6 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 1: ASCVD
Dr. Ahmadi highlights the need for early detection and treatment of atherosclerosis with advanced imaging and AI to prevent heart attacks.


Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 1: From Intervention to Prevention
Dr. Mehran highlights the shift to prevention in cardiology, stressing optimized stent placement, personalized regimens, and LDL-lowering.


Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 - Welcome and Introduction by Dr. David Yankelevitz
Dr. David Yankelevitz highlights the integration of lung cancer screening with cardiology, emphasizing AI's role in preventive health.


Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 - Welcome and Introduction by Dr. Claudia Henschke
Dr. Claudia Henschke highlights 30 years of progress in lung cancer screening, sharing milestones and future goals for improved outcomes.


Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT" are now available: Day 1 - Welcome and Introduction by Dr. Morteza Naghavi
Dr. Morteza Naghavi gave an introductory presentation at the 1st Conference on Integrating Early Detection of Heart and Lung Disease


Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 - Opening Remarks: CVD Burden in 2050 without New Prevention Strategies
Dr. Robert Harrington urges early cardiovascular risk detection, public health measures, and policy reforms to combat rising disease rates.


Video Presentations of the 1st Conference on "Integrating Early Detection of Heart and Lung Disease through Low-Dose CT" are now available for the public: Day 1 - Welcome and Introduction
Dr. Claudia Henschke, Dr. Morteza Naghavi, and Dr. David Yankelevitz gave a warm welcome and introductory presentations.


HeartLung's distinguished advisor, Dr. Claudia Henschke, who pioneered lung cancer screening, wins the RSNA 2024 Scientific Excellence Award 🏆⚕️
HeartLung collaborator, Dr. Claudia Henschke, has been honored with the prestigious Scientific Excellence Award at #RSNA2024!


HeartLung Technologies to Present Four Scientific Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at the 2024 Radiological Society of North America (RSNA 2024)
HeartLung is the only AI company participating in RSNA 2024 as a scientific presenter of research studies and as an industry exhibitor


HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the Annual Scientific Sessions of the American Heart Association 2024
Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential for primary prevention...


HeartLung Technologies Receives FDA “Breakthrough” Designation and Marketing Authorization for AutoChamber™
The First AI that Enables Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans SUMMARY: HeartLung Technologies (...


Dr. Claudia Henschke receives esteemed Joseph W. Cullen Prevention/Early Detection Award at #WCLC2024!
Thrilled to share some fantastic news! 🎉 HeartLung collaborator, Dr. Claudia Henschke, has been recognized with the esteemed Joseph W....


Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London
Pioneering research by Dr. Naghavi's team from American Heart Technologies and HeartLung.AI highlights AI's transformative impact on...
bottom of page